| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding cisplatin to split course radiotherapy increases progression-free survival compared to radiotherapy alone in people with inoperable squamous cell esophageal cancer
|
Ilson, D.H.
|
|
2001
|
2 |
4 |
p. 221-223
3 p.
|
artikel
|
| 2 |
Adding interferon to fluorouracil regimens does not improve survival in people with advanced colorectal cancer
|
Zaniboni, Alberto
|
|
2001
|
2 |
4 |
p. 214-215
2 p.
|
artikel
|
| 3 |
Adding interleukin 2 to dacarbazine and interferon has no survival or tumor response benefit for metastatic melanoma
|
Dillman, Robert O
|
|
2001
|
2 |
4 |
p. 197-199
3 p.
|
artikel
|
| 4 |
Adding mitomycin to other active chemotherapy agents does not improve survival in people with non-small cell lung cancer
|
Abratt, Raymond P.
|
|
2001
|
2 |
4 |
p. 186-187
2 p.
|
artikel
|
| 5 |
Brief infusion of 2 or 4 mg zoledronate is as effective as prolonged infusion of 90 mg pamidronate for osteolytic metastases
|
Major, Pierre P.
|
|
2001
|
2 |
4 |
p. 191-192
2 p.
|
artikel
|
| 6 |
Capecitabine reduces medical resource use for advanced colorectal carcinoma compared with 5-fluorouracil plus leucovorin
|
Vincent, Mark
|
|
2001
|
2 |
4 |
p. 224-226
3 p.
|
artikel
|
| 7 |
β-carotene may not prevent second head and neck cancer
|
Jack Lee, J.
|
|
2001
|
2 |
4 |
p. 200-201
2 p.
|
artikel
|
| 8 |
Changes in dose and route of gamolenate have no positive effect on survival in people with inoperable pancreatic cancer
|
Jiang, Wen G.
|
|
2001
|
2 |
4 |
p. 216-217
2 p.
|
artikel
|
| 9 |
Cyclophosphamide, epirubicin and fluorouracil controls metastatic breast tumors more effectively than cyclophosphamide, methotrexate, and fluorouracil
|
Pagani, Olivia
|
|
2001
|
2 |
4 |
p. 183-185
3 p.
|
artikel
|
| 10 |
Dermal injection of radioactive colloid is more effective than peritumoral injection for sentinel lymph node identification in women with breast cancer
|
Tafra, Lorraine
|
|
2001
|
2 |
4 |
p. 179-180
2 p.
|
artikel
|
| 11 |
Dose-dense sequential administration and same day administration of epirubicin and paclitaxel yield similar response rates in women with advanced breast cancer
|
Mastro, Lucia Del
|
|
2001
|
2 |
4 |
p. 211-213
3 p.
|
artikel
|
| 12 |
Doxorubicin and paclitaxel improve survival compared with fluorouracil, doxorubicin and cyclophosphamide for women with metastatic breast cancer
|
Ludwig, Heinz
|
|
2001
|
2 |
4 |
p. 202-204
3 p.
|
artikel
|
| 13 |
EDITORIAL
|
|
|
2001
|
2 |
4 |
p. 171-
1 p.
|
artikel
|
| 14 |
Glossary of terms
|
|
|
2001
|
2 |
4 |
p. 227-228
2 p.
|
artikel
|
| 15 |
Hormone replacement therapy may have no significant effect on breast cancer recurrence
|
Carlson, Robert W.
|
|
2001
|
2 |
4 |
p. 181-182
2 p.
|
artikel
|
| 16 |
80% increase in dose intensity of cyclophosphamide, epirubicin and fluorouracil does not improve metastatic breast cancer response rate
|
Riccardi, Alberto
|
|
2001
|
2 |
4 |
p. 193-196
4 p.
|
artikel
|
| 17 |
Moderately high-dose carboplatin with paclitaxel and intraperitoneal cisplatin improves progression-free survival but has higher toxicity than standard intravenous cisplatin and paclitaxel for small volume ovarian cancer
|
Lena, Mario De
|
|
2001
|
2 |
4 |
p. 205-207
3 p.
|
artikel
|
| 18 |
Oral capecitabine is associated with higher tumor response rates and tolerability than intravenous fluorouracil plus leucovorin for metastatic colorectal cancer
|
Mani, Sridhar
|
|
2001
|
2 |
4 |
p. 208-210
3 p.
|
artikel
|
| 19 |
Oral contraceptives may lower the risk of colorectal cancer
|
Piedbois, Pascal
|
|
2001
|
2 |
4 |
p. 177-178
2 p.
|
artikel
|
| 20 |
Protracted high-dose L-asparaginase has no benefit for intermediate risk childhood acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Munster chemotherapy
|
Ishii, Eiichi
|
|
2001
|
2 |
4 |
p. 218-220
3 p.
|
artikel
|
| 21 |
Table A. Levels of evidence and grades of recommendations
|
|
|
2001
|
2 |
4 |
p. 229-
1 p.
|
artikel
|
| 22 |
Three and four cycles of bleomycin, etoposide and cisplatinare equivalent in the treatment of good prognosis germ cell cancer
|
Toner, Guy C.
|
|
2001
|
2 |
4 |
p. 188-190
3 p.
|
artikel
|
| 23 |
Understanding outcome measures
|
Meyer, Ralph M.
|
|
2001
|
2 |
4 |
p. 172-176
5 p.
|
artikel
|
Tijdschrift beschrijving